258 related articles for article (PubMed ID: 31075171)
1. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
3. Host immunity to
Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
[TBL] [Abstract][Full Text] [Related]
4. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
[TBL] [Abstract][Full Text] [Related]
6. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Lopera-Mesa TM; Doumbia S; Chiang S; Zeituni AE; Konate DS; Doumbouya M; Keita AS; Stepniewska K; Traore K; Diakite SA; Ndiaye D; Sa JM; Anderson JM; Fay MP; Long CA; Diakite M; Fairhurst RM
J Infect Dis; 2013 Jun; 207(11):1655-63. PubMed ID: 23448727
[TBL] [Abstract][Full Text] [Related]
7. Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.
Noland GS; Jansen P; Vulule JM; Park GS; Ondigo BN; Kazura JW; Moormann AM; John CC
Acta Trop; 2015 Feb; 142():47-56. PubMed ID: 25446174
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA
J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768
[TBL] [Abstract][Full Text] [Related]
9. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
[TBL] [Abstract][Full Text] [Related]
10. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M; Sutherland CJ; Sisay-Joof F; Ismaili J; McCall MB; Ord R; Hallett R; Holder AA; Milligan P
Infect Immun; 2006 May; 74(5):2887-93. PubMed ID: 16622227
[TBL] [Abstract][Full Text] [Related]
12. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
[TBL] [Abstract][Full Text] [Related]
13. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
[TBL] [Abstract][Full Text] [Related]
14. Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.
Aubouy A; Migot-Nabias F; Deloron P
Infect Genet Evol; 2007 Mar; 7(2):147-54. PubMed ID: 16890498
[TBL] [Abstract][Full Text] [Related]
15. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.
Villasis E; Lopez-Perez M; Torres K; Gamboa D; Neyra V; Bendezu J; Tricoche N; Lobo C; Vinetz JM; Lustigman S
Malar J; 2012 Oct; 11():361. PubMed ID: 23110555
[TBL] [Abstract][Full Text] [Related]
16. Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.
Kana IH; Garcia-Senosiain A; Singh SK; Tiendrebeogo RW; Chourasia BK; Malhotra P; Sharma SK; Das MK; Singh S; Adu B; Theisen M
J Infect Dis; 2018 Aug; 218(6):956-965. PubMed ID: 29733355
[TBL] [Abstract][Full Text] [Related]
17. Induction and Kinetics of Complement-Fixing Antibodies Against Plasmodium vivax Merozoite Surface Protein 3α and Relationship With Immunoglobulin G Subclasses and Immunoglobulin M.
Oyong DA; Wilson DW; Barber BE; William T; Jiang J; Galinski MR; Fowkes FJI; Grigg MJ; Beeson JG; Anstey NM; Boyle MJ
J Infect Dis; 2019 Nov; 220(12):1950-1961. PubMed ID: 31419296
[TBL] [Abstract][Full Text] [Related]
18. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
Chan JA; Stanisic DI; Duffy MF; Robinson LJ; Lin E; Kazura JW; King CL; Siba PM; Fowkes FJ; Mueller I; Beeson JG
Eur J Immunol; 2017 Dec; 47(12):2124-2136. PubMed ID: 28833064
[TBL] [Abstract][Full Text] [Related]
19. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria.
Boyle MJ; Reiling L; Feng G; Langer C; Osier FH; Aspeling-Jones H; Cheng YS; Stubbs J; Tetteh KK; Conway DJ; McCarthy JS; Muller I; Marsh K; Anders RF; Beeson JG
Immunity; 2015 Mar; 42(3):580-90. PubMed ID: 25786180
[TBL] [Abstract][Full Text] [Related]
20. Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.
Nhabomba AJ; Guinovart C; Jiménez A; Manaca MN; Quintó L; Cisteró P; Aguilar R; Barbosa A; Rodríguez MH; Bassat Q; Aponte JJ; Mayor A; Chitnis CE; Alonso PL; Dobaño C
Malar J; 2014 Mar; 13():121. PubMed ID: 24674654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
